Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, to Take Medical Leave (ACUR)

Acura Pharmaceuticals ACUR announced that President and Chief Executive Officer Andy Reddick has begun a leave of absence for health reasons for an as-yet undetermined period. Mr. Reddick will continue to serve as a member of the Company's Board of Directors. During Mr. Reddick's absence, Bob Jones, the Company's Chief Operating Officer, will assume day-to-day responsibilities and Richard Markham will continue in his role as non-executive Chairman of the Board.